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amine that exists as a zwitterion under physiological 
conditions 1）. In eukaryotic cells, carnitine is biological­
ly important for mitochondrial b-oxidation of long-
chain fatty acids and to generate ATP in peripheral 
tissues such as muscle, heart and liver 1）. In recent 
years, a different physiological role of L-carnitine has 
been proposed：control of acetyl moiety level in neu­
ral cells for acetylcholine synthesis 2）. Acetyl-L-carni­
tine, endogenous metabolite of L-carnitine, is a source 
of acetyl groups available for acetylcholine synthesis 
and is selectively taken up by the primate brain 2）. 
INTRODUCTION
L-Carnitine（4-N-trimethylammonium-3-hydroxybu­
tyric acid）is a highly polar, water-soluble quaternary 
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ABSTRACT
L-Carnitine is an essential component of mitochondrial fatty acid b-oxidation in the muscle and may con­
trol the acetyl moiety levels in the brain for acetylcholine synthesis. Carnitine transporter 1（CT1）is the 
high affinity L-carnitine transporter whose localization was observed in the kidney, testis, liver, skeletal 
muscle and brain. To clarify the molecular mechanism of carnitine transport, we sought to find the inter­
acting protein that may be related to the transport function of CT1. Using the intracellular C-terminal 
region of rat CT1 containing PDZ（PSD95/DLG/ZO-1）motif as bait, we performed the yeast two-hybrid 
screening against rat brain cDNA library. Thirty two positive clones were obtained from the 2.7×10 7 
clones screened. One of them was PDZ domain-containing protein Lin-7. We found that Lin-7 interacts 
specifically with C-termini of CT1：deletion and mutation of the CT1 C-terminal PDZ-motif abolished the 
interaction with Lin-7 in the yeast two-hybrid assay. In addition, a PDZ domain within Lin-7 associates 
with the CT1 C-terminal. The association of CT1 with Lin-7 enhanced L-carnitine transport activities in 
HEK293 cells although there is no statistical significance. Coexpression of Lin-7 and CT1 is identified in 
motor neurons of the spinal cord ventral horn together with Lin-2, a binding partner of Lin-7 known to 
assemble proteins involved in synaptic vesicle exocytosis and synaptic junctions. Therefore, Lin-7 interacts 
with CT1 and may regulate their subcellular distribution or function in central nervous system.
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These functions may lead to the beneficial effcts of 
acetyl-L-carnitine against ischemic change, degenerat­
ing disease（Alzheimer disease and dementia）and 
age-related changes in brain 3）.
Carnitine transporter CT1（Slc22a5）, also termed 
as Octn2, was isolated from rat intestine and mediates 
a high-affinity sodium-dependent transport of L-carni­
tine 4,5）. Systemic carnitine deficiency（SCD, OMIM 
212140）in human and in juvenile visceral steatosis
（jvs）mouse is caused by the mutations of SLC22A5/
Slc22a5 5）. CT1-mediated L-carnitine uptake was 
strongly inhibited by acetyl-L-carnitine, suggesting 
that acetyl-L-carnitine is putative transport substrate 
of CT1. CT1 mRNA was strongly expressed in the 
testis, colon, kidney and liver, and weakly in the skele­
tal muscle and brain 4）. Since the brain depends on 
carnitine supplied from the plasma, control of the 
transport function of CT1 seems to be essential for 
the neuronal cell metabolism. Therefore, it is suggest­
ed that the transport of both L-carnitine and acetyl-L-
carnitine via CT1 is important to maintain the homeo­
stasis in the central nervous system（CNS）.
A number of recent studies have shown that associ­
ation of neuronal ion channels and receptors with 
adapter and cytoskeletal proteins such as PDZ protein 
influences their localization and regulation 6）. We have 
performed the yeast two-hybrid screening to identify 
the interacting proteins for CT1 and to clarify the 
regulation mechanism of carnitine transport in CNS. 
Here we report that the PDZ protein Lin-7 interacts 
with the C terminus of CT1 and that Lin-7 and CT1 
are coexpressed in rat brain such as neurons in the 
spinal cord ventral horn.
METHODS
Materials
L-［
3H］carnitine hydrochloride（84 Ci/mmol）was 
obtained from Amersham Pharmacia Biotech（Uppsala, 
Sweden）. All other chemicals and reagents used were 
of analytical grade and obtained from commercial 
sources. A rat brain cDNA library for the yeast two-
hybrid screening was purchased from OriGene Tech­
nologies（Rockville, MD）.
Plasmid construction
The C-terminal fragments of wild-type rat CT1 
cDNA and three mutants（designated D3, F557A, and 
T555A）were generated by PCR using specific prim­
ers（Table 1）and cloned into the Eco RI and Xho I 
sites of bait vectors（pEG202）to construct CT1-C-
terminus（CT）wt, CT1-CTD 3 , CT1-F557A, and 
CT1-T555A. The pcDNA3.1 vector containing the 
full-length rat Lin-7（rLin-7）and preys（pJG4-5）con­
taining L27 and PDZ domains of rLin-7 were pre­
pared as described previously 7）.
Yeast two-hybrid assay
A CT1 C-terminal bait corresponding to the last 39 
amino acids of CT1 was used to screen 4 .5×10 6 
clones of the rat brain cDNA library with the LexA-
based GFP two-hybrid system（Grow’n’ Glow sys­
tem；MoBiTec）as described previously 7）. Several 
positive clones were obtained and confirmed in a sec­
ond round of screening using the yeast system. The 
expression of all the bait constructs in yeast was con­
firmed by western blot analysis of yeast protein 
extracts using an anti-LexA antibody（Santa Cruz 
Biotechnology）（data not shown）.
Preparation of Antibodies
Corresponding to the 14 amino acids of the NH2-
terminus of rat CT1, rabbit anti-CT1 polyclonal anti­
body raised against the keyhole limpet hemocyanin-
conjugated synthesized peptides, MTSTFNPREC
Table 1　PCR primers used in this study
Construct Sense primer Antisense primer
CT1-CT-wt 5’-CGAATTCCCCGACACCATTGACCA-3’ 5’-CCCTCGAGTTAGAAGGCTGTGCTC-3’
CT1-CT-D3 5’-CGAATTCCCCGACACCATTGACCA-3’ 5’-CTCTCGAGTTAGCTCTTTAGGACCGTTG-3’
CT1-F557A 5’-CGAATTCCCCGACACCATTGACCA-3’ 5’-CCCTCGAGTTAGGCGGCTGTGCTCTTTAGGAC-3’
CT1-T555A 5’-CGAATTCCCCGACACCATTGACCA-3’ 5’-CTCTCGAGTTAGAAGGCTGCGCTC-3’
Lin7-L27 domain 5’-CGAATTCATGGCTGCGCTGGTGGAG-3’ 5’-CTCTCGAGTCAATGGGCATGGCCCTCAC -3’
Lin7-PDZ domain 5’-CGAATTCCCCAGGGTCGTGGAACTA-3’ 5’-CTCGTCGACTCACTCCTCCAGCACCCGAG-3’
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（amino acids 1-10 of the rat CT1 amino acid sequ­
ence）was generated.
Immunohistochemistry
Eight-week-old male Wistar rats weighing 250-300 
g（SLC, Shizuoka, Japan）were anesthetized by intra­
peritoneal injection of pentobarbital（5 mg/100 g body 
weight；Abbott, North Chicago, IL, USA）, and per­
fused transcardially with ice-cold 25 mM phosphate-
buffered saline（pH7.4）, followed by a fixative contain­
ing 3％ paraformaldehyde in 0.1 M phosphate buffer
（PB）. Brains and spinal cords were dissected out, 
cryoprotected with 0.1 M PB（pH 7.4）containing 20％ 
glycerol for 16 h at 4℃ and frozen with dry-ice. Fro­
zen sections 30 µm thick were prepared using a slid­
ing microtome. The sections were then subjected to 
the immunohistochemical staining for CT1.
Briefly, free-floating sections were rinsed with TBS, 
incubated for 1 h in a blocking solution containing 5％ 
normal goat serum（NGS）, 0 .5％ Triton X-100 in 
Tris-buffered saline（TBS, pH 7.4）, and then in the 
blocking solution containing anti-CT1（1：200）for 16 
h at 4℃. After rinsing with TBS, the sections were 
incubated with biotinylated anti-rabbit IgG（1：200, 
BA-1000 , Vector, Burlingame, CA, USA）in TBS, 
rinsed with TBS and processed using Elite ABC Stan­
dard Kit（PK-6100, Vector）. After rinsing with 0.1 M 
PB, localization of HRP was visualized with 0.02％ 
DAB and 0.003％ H2O2 in 50 mM Tris-Cl solution, pH 
7.4 for 5-10 min. The sections were then mounted, 
dehydrated and coverslipped with DPX（Fluka, Buchs, 
Switzerland）. As a control, the primary antibody was 
replaced with the same concentration of rabbit pre-
immune IgG. For absorption experiments, primary 
antibody was absorbed with 100 µg/ml of synthetic 
peptide for 16 h at 4℃ prior to immunohistochemis­
try.
Images were photographed using a microscope（BX-
60, Olympus）equipped with a digital CCD camera
（DP50, Olympus）.
Double immunostaining method using two antibodies 
from rabbits
Since our antibodies for CT1, Lin-7 and Lin-2 were 
made from rabbits, we employed ECSS, a new method 
for chromogen-based immunohistochemical method 
for elucidation of the co-expression of two antigens 
using antibodies from the same species 8）.
In brief, sections（30 um）were rinsed several times 
in TBS and incubated in a blocking solution contain­
ing 5％ Normal goat serum（NGS）and 0.5％ Triton in 
TBS for 1 h. The sections were then incubated for 
16h at 4℃ in the primary antibody solution After 
rinsing in TBS, the sections were incubated with 
HRP-Labeled anti-rabbit secondary antibody solution
（K4002, DakoCytomation, Kyoto, Japan）for 1h fol­
lowed by development with AEC（K3464, Dakocyto­
mation, Japan）. The sections were rinsed in 0.1M PB
（pH 7.4）, mounted temporarily on slides and photo­
graphed using the microscope system mentioned 
above. After removing coverslips, sections were 
microwaved in 10 mM Citrate buffer（pH 6.0）for ten 
minutes to inactivate the antigenecity of IgG and the 
HRP enzyme activity. Subsequently, the sections were 
incubated in the second primary antibody solution, 
rinsed with TBS and incubated with HRP-Labeled 
anti-rabbit secondary antibody solution（K4002, Dako­
Cytomation, Kyoto, Japan）. After rinsing in TBS, the 
sections were stained with 50 mM Tris-Cl（pH 7.4）
containing 0.02％ DAB and 0.001％ H2O2. After rins­
ing with 0.1 M PB, the sections were dehydrated and 
coverslipped with DPX. In this step, AEC staining on 
the sections were dissolved in the organic solvents so 
that the sections did not show any signal for the first 
primar antibody. The same areas were photographed 
again to show the coexpression of the signals. Since 
no labeling was observed following the omission of the 
primary antibody in the second staining, there was 
virtually no cross-reactivity between the first staining 
and the second staining.
The primary antibodies used in this study were list­
ed below：polyclonal rabbit anti-CT1（1：100, origi­
nal）, polyclonal rabbit anti-Lin-7（1：100, SIGMA）, 
polyclonal rabbit anti-Lin-2（1：100, SIGMA）
Cell culture and transfection
Human embryonic kidney 293（HEK293）cells were 
maintained in Dulbecco’s modified Eagle’s medium
（DMEM）supplemented with 10％ fetal bovine serum
（FBS）, 1 mM sodium pyruvate, 100 U/ml penicillin, 
and 100 mg/ml streptomycin（Invitrogen）at 37ºC and 
5％ CO2. Transient transfection with Lipofectamine 
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2000（Invitrogen, Gaithersburg, MD）was performed 
according to the manufacturer’s instructions. After 
transfection, the cells were grown 36-48 h before the 
experiments.
Carnitine transport activity assay
HEK293 cells were plated on 24-well culture plates 
at a density of 2×10 5 cells/well 24 h prior to transfec­
tion, and they were transfected as described above. 
After 36 h, the culture medium was removed, and the 
cells were washed three times and incubated in 
serum-free Hank’s solution（containing in mM：125 
NaCl, 5 . 6 glucose, 4 . 8 KCl, 1 . 2 MgSO4・7H2O, 1 .2 
KH2PO4, 1 .3 CaCl2・2H2O, 25 HEPES（pH 6.0））for 
10 min. The uptake study was started by adding 
500 µl of solution containing 40 nM ［3H］carnitine to 
the plate. After 2 min, the cells were washed twice in 
an ice-cold solution, and lysed in 0 .1 N NaOH for 
20 min for scintillation counting.
Statistical analysis
Uptake experiments were conducted three times, 
and each uptake experiment was performed in tripli­
cate. Values are presented as the mean±standard 
error. Statistical significance was determined by Stu­
dent’s t test. Differences were considered significant at 
P＜0.05.
RESULTS
Isolation of Lin-7 in yeast two-hybrid genetic screen
In our search for putative CT1 binding partners, 
we used the CT1 C-terminal tail（CT1-CT）as bait in 
a yeast two-hybrid screen of a cDNA library of the 
rat adult brain. From 2.7×10 7 independent colonies 
screened, 32 positive clones were obtained. Of these 
positive clones, 1 yielded an identical sequence encod­
ing some portions of the gene for rat Lin-7. Lin-7 is a 
2 9 7-amino acid protein that contains one PDZ 
domain 9,10）（GenBank accession number AF012281）. 
We could not detect interaction between the CT1-CT 
with any other PDZ proteins from rat brain cDNA 
library. For further experiments, we cloned full-length 
rat Lin-7 by long PCR and subcloned it into a prey 
vector.
The C-terminus of CT1 is necessary for the interac-
tion with Lin-7
To identify the sites in CT1 that interact with Lin-
7, we made three mutant baits. The first one（CT1-
CTΔ3）is a bait that lacks the last three residues of 
CT1, which are known to play a crucial role in PDZ 
domain recognition. The second and third ones
（F557A and T555A）, the extreme C-terminal phenyl­
alanine（0 position）or threonine（-2 position）of CT1, 
have been replaced by alanine, which was expected to 
abolish or strongly suppress the binding of PDZ pro­
teins 6）. These three baits did not interact with Lin-7
（Fig. 1A）. Thus, binding through the C-terminus of 
CT1 suggests that the PDZ motif of CT1 is the site of 
interaction with Lin-7.
Domain analysis of Lin-7 protein-protein interaction 
with CT1 C-terminus
Lin-7 possesses two kinds of protein-protein inter­
action modules. One is L27（Lin2/7）domain that pref­
erentially hetero-dimerize and another is PDZ domain 
that assemble target proteins by binding to a C-ter­
minal motif with a consensus sequence such as（S/T）
-X-Ø. To determine the possible interactions of the 
CT1 C-terminal region with the PDZ domains of Lin-
7 , we produced prey vectors each containing L27 
domain or PDZ domain. The interaction with CT1 
C-terminus was observed for PDZ domain of Lin-7 
but not for L27 domain（Fig. 1B）.
Effect of Lin-7 coexpression on CT1 transport activity
To determine whether CT1/Lin-7 interactions 
change CT1 activity, we transfected transiently 
HEK293 cells with the pcDNA3.1（＋）construct con­
taining full-length CT1. At an incubation time of 
1 minutes, we demonstrated that the uptake of ［3H］
carnitine by the wild-type CT1 was from 2.8-fold 
higher than that by the mock（Fig. 2）. When full-
length CT1 coexpressed with pcDNA3.1（＋）contain­
ing Lin-7, the coexpression clearly increased carnitine 
transport activity by 1.2-folds（Fig. 2）although there 
is no statistical significance.
Coexpression of CT1 and Lin-7 in the rat brain
Colocalization of CT1 , Lin-7 and Lin-2 were 
observed in motor neurons in the ventral horn of the 
lumbar enlargement（Fig. 3a, 3c, 3d）. These signals 
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were disappeared by absorbing the primary antibody 
with the synthetic peptide prior to immunohistochem­
istry（Fig. 3b）. Both CT1 and Lin-7 signals were 
observed in the same neurons（arrows in Fig. 3e and 
3i）. In the control experiments, no cross reactivity 
was observed between the first and second stainings
（arrowhead in Fig. 3 f-h and 3j-l）. Both CT1 and 
Lin-2 signals were observed in the same neurons
（arrows in Fig. 3 m and 3n）. On the other hand, some 
neurons exhibited only CT1 signals（arrowheads in 
Fig. 3 m and 3n）. In the control experiments where 
the primary antibody was omitted in the second stain­
ing, no cross reactivity was observed between the 
first and second stainings（arrowhead in Fig. 3o and 
3p）.
DISCUSSION
CT1 is thought to be importance in regulating blood 
carnitine level in the body. Through a yeast two-
hybrid screen of a rat brain cDNA library, we identi­
fied Lin-7 as a binding partner of CT1. Lin-7 is a 
PDZ domain-containing protein that was originally 
identified as a protein that directly interacts with 
Lin-2（or CASK）, another PDZ protein in the syn­
apse 11,12）. In addition to Lin-2, Lin-7 has also been 
reported to interact with several membrane proteins 
through its PDZ domain；these proteins include LET 
23 receptor tyrosine kinase 13）, acid-sensing ion chan­
nel ASIC3 14）, Kir2.3 channel 15）, GABA transporter 
C terminal LEU GFP
CT1-CTwt L K S T A F + +
CT1-CTΔ3 L K S － －
CT1-F557A L K S T A A － －
CT1-T555A L K S A Q F － －
Lin7 LEU GFP
L27 domain - -
PDZ domain + +
L27 PDZ
N C
L27
PDZ
A
B
Fig. 1　 Specificity of Lin-7 for interaction with C-terminus of CT1 in the 
yeast two-hybrid system
A, Lin-7 specifically interacted with C-terminal wild-type CT1 but not 
with the C-terminal CT1 mutants D 3（555-557）, F557A and T555A and. 
B, the CT1 C-terminal wild-type bait interacts with the prey containing 
PDZ domain of Lin-7, but not with the prey containing only L27 domain. 
The bars represent the approximate length of the baits, and the sequence 
of the last 10 amino acids is shown. The system used for the two-hybrid 
screen includes the reporter genes LEU2 and GFP, which replace the com­
monly used lacZ gene；it allows a fast and easy detection of positive 
clones with long-wave length UV. The results of growth assay and GFP 
fluorescence monitoring are shown on the right.
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Fig. 2　 Effect of Lin-7 on［3H］carnitine transport 
activity
Coexpression of CT1 and Lin-7 increased carni­
tine uptake（40 nM）clearly but not significantly 
in cells transfected with CT1 alone. ＊, p＜0.05.
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BGT116）, and cholesterol transporter ABCA117）. Lin-7 
can function as a tripartite complex of Lin-7, Lin-2 
and Lin-10 18）. To form this complex, N-terminal of 
Lin-7（L27 domain）interacts with the PDZ domain of 
Lin-2. And the CaM kinase domain of Lin-2 interacts 
with N-terminal of Lin-10 . PDZ domain of Lin-7 
interacts with the interacting protein mentioned earli­
er. The Lin-2/7/10 complex plays the direct role as 
the membrane protein targeting especially for basolat­
eral localization of LET 23 RTK and neurotransmitter 
receptor on the postsynaptic neuron in the brain 9）.
PDZ（PSD-95, DglA, and ZO-1）domains have been 
identified in various proteins and are known to be 
modular protein-protein recognition domains that play 
a role in protein targeting and protein complex assem­
bly. These domains range from 80 to 90 amino acids 
in length and bind typically to proteins containing the 
tripeptide motif（S/T）-X-Ø（X＝any amino acid and 
Ø＝a hydrophobic residue）at their C-termini. These 
multidomain molecules not only target and provide 
Fig. 3　Colocalization of CT1 and Lin-7 in nervous system
Localization of CT1（a）, Lin-7（c）and Lin-2（d）in the ventral horn of the lumbar enlargement. Note that 
the signals were observed in motor neurons. These signals were disappeared by absorbing the primary 
antibody with the synthetic peptide prior to immunohistochemistry（b）. Coexpression of endogenous CT1 
and Lin-7 in motor neurons of the ventral horn（e-l）. Both CT1 and Lin-7 signals were observed in the 
same neurons（arrows in e and i）. In the control experiments, no cross reactivity was observed between 
the first and second stainings（arrowhead in f, g, j and k）.（f and j）The primary antibody was omitted in 
the second staining.（g and k）The primary antibody was omitted in the first staining.（h and l）The pri­
mary antibodies were omitted both in the first and second staining. Coexpression of CT1 and Lin-2 in 
motor neurons of the ventral horn（m-p）. Both CT1 and Lin-2 signals were observed in the same neurons
（arrows in m and n）. On the other hand, some neurons exhibited only CT1 signals（arrowheads in m and 
n）. In the control experiments where the primary antibody was omitted in the second staining, no cross 
reactivity was observed between the first and second stainings（arrowhead in o and p）. Scale bars＝50 µm.
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scaffolds for protein-protein interactions but also mod­
ulate the function of receptors and ion channels, by 
which they associate. The disruption of the association 
between PDZ proteins and their targets contributes 
to the pathogenesis of a number of human diseases, 
most probably because of the failure of PDZ proteins 
to appropriately target and modulate the actions of 
associated proteins 6）.
Here we report the specific interaction between 
CT1 and Lin-7 as demonstrated by yeast two-hybrid 
assays and colocalization experiments. The C-terminal 
of CT1（S-T-A-F）constitutes with class I（S/
T-X-Ø）of the PDZ-binding motif 6）. All the proteins 
that interact with Lin-7 have the PDZ-binding motif 
belonging to class I；LET-23 RTK, E-T-C-L 13）：
ASIC3 , V-T-Q-L 14）：Kir2 .3 , E-S-A-I 15）：BGT1 , 
E-T-H-L16）：and ABCA1, E-S-Y-V17）. The results 
obtained using the various mutants of the CT1 C-ter­
minal in yeast two-hybrid assays（Fig. 1）confirmed 
the importance of the 0 and –2 positions of the PDZ-
binding motif.
The carnitine transport study revealed that the 
coexpression of Lin-7 with CT1 in HEK293 cells leads 
to an enhancement of CT1-mediated ［14C］carnitine 
transport although it was not statistical significant
（Fig. 2）. Previously, we demonstrated that PDZK1, 
another PDZ protein that has four PDZ domains 
expressed in several epithelial tissues, interacts and 
alters the transport function of renal apical transport­
ers such as URAT118）, OAT419）, and PEPT220）, so we 
examined the possibility that PDZ protein Lin-7 inter­
acts CT1 and alters its transport function. Since there 
is no report concerning the functional alteration after 
the binding with Lin-7 to its interacting proteins, the 
association of Lin-7 with CT1 may be a new example 
of the role of Lin-7 in modulating the function of their 
associated proteins.
Rat CT1 mRNA expression was detected in brain as 
well as the testis, colon, kidney, liver, the skeletal 
muscle, placenta, and small intestine 4）. Northern blot 
analysis revealed a message of rat Lin-7 in heart, 
brain, spleen, lung, liver, skeletal muscle, kidney, and 
testis 10）. Based on these reports, it seemed to be not 
difficult to detect the coexpression of CT1 and Lin-7 
but it was not so easy. We could detect the CT1 pro­
tein expression in several region of the brain：for 
example, in the neocortex, signals were localized in 
the cell bodies and dendrites of pyramidal cells in lay­
ers II, III, V, and VI：in the cerebellum, signals were 
localized in the cell bodies and dendrites of Purkinje 
cells：in the hippocampus, the dentate granule cells 
and the pyramidal cells in Ammon’s horn showed 
strong signals（data not shown）. Although we could 
detect CT1 protein expression in those regions, we 
could not confirm the colocalization of Lin-7. After 
the several efforts, we finally found the coexpression 
of CT1 and Lin-7 together with Lin-2 in motor neu­
rons of the ventral horn（Fig. 3）. These results con­
firm that the protein-protein interaction between CT1 
and Lin-7 is not artificial due to the yeast two-hybrid 
screen but truly occurs in native tissues with physio­
logical importance.
CONCLUSION
In summary, we have identified that the PDZ pro­
tein Lin-7 is a binding partner of CT1, which may 
regulate CT1-mediated carnitine transport activity. A 
further study of transporter-interacting proteins, such 
as PDZ proteins, will encourage our understanding of 
the important regulatory mechanisms different from 
other transporters.
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